1.Effects of the flavonoids on cytochrome P-450 CYP1, 2E1, 3A4 and 19.
Acta Pharmaceutica Sinica 2007;42(1):8-12
Flavonoids are present in fruits, vegetables and beverages derived from plants, and in many dietary supplements or herbal remedies. A number of naturally occurring flavonoids have been shown to modulate the CYP450 system, including the induction or inhibition of these enzymes. This review focuses on the flavonoid effects on cytochrome P450 (CYP) enzyme CYP1, 2E1, 3A4 and 19. Flavonoids alter CYPs by various mechanisms, including the stimulation of gene expression via specific receptors and/or CYP protein, or mRNA stabilization and so on. But in vivo and in vitro, the effects of flavonoids are not always coincident as a result of concentrations of flavonoids, genetic and environmental factors. As well, flavonoids may interact with drugs through the induction or inhibition of their metabolism. Much attention should be paid to the metabolism interaction of the flavonoids when coadministered with other drugs.
Animals
;
Aromatase
;
genetics
;
metabolism
;
Cytochrome P-450 CYP1A1
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1
;
genetics
;
metabolism
;
Cytochrome P-450 CYP2E1 Inhibitors
;
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
Cytochrome P-450 Enzyme Inhibitors
;
Cytochrome P-450 Enzyme System
;
genetics
;
metabolism
;
Enzyme Activation
;
drug effects
;
Flavonoids
;
pharmacology
;
Humans
;
RNA, Messenger
;
genetics
;
metabolism
2.Investigation on the hydroxylation metabolism of imrecoxib in vitro by using recombinant human CYPs.
Qiang LI ; Hai-Hua HUANG ; Yu DONG ; Da-Fang ZHONG
Acta Pharmaceutica Sinica 2005;40(10):912-915
<p>AIMTo identify the drug-metabolizing enzymes involved in the hydroxylation of the new anti-inflammatory and anodyne imrecoxib.p><p>METHODSImrecoxib was incubated with heterologous expression human cytochrome P450 (rCYPs) in vitro, and metabolites and remained parent drug were detected with liquid chromatography-multistage mass spectrometry. The contribution of 4 CYPs in the hydroxylation metabolism of imrecoxib was evaluated by total normalized rate (TNR) method.p><p>RESULTSImrecoxib is metabolized by CYP2C9, CYP2D6 and CYP3A4, with the rate of 62.5%, 21.1% and 16.4%, respectively.p><p>CONCLUSIONCYP2C9 is the major enzyme involved in imrecoxib hydroxylation metabolism.p>
Aryl Hydrocarbon Hydroxylases
;
metabolism
;
Cyclooxygenase 2 Inhibitors
;
metabolism
;
Cytochrome P-450 CYP2C9
;
Cytochrome P-450 CYP2D6
;
metabolism
;
Cytochrome P-450 CYP3A
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Hydroxylation
;
Pyrroles
;
metabolism
;
Spectrometry, Mass, Electrospray Ionization
;
Sulfides
;
metabolism
3.Metabolites and metabolic pathways of mesaconitine in rat liver microsomal investigated by using UPLC-MS/MS method in vitro.
Yun-Feng BI ; Shu LIU ; Rui-Xing ZHANG ; Feng-Rui SONG ; Zhi-Qiang LIU
Acta Pharmaceutica Sinica 2013;48(12):1823-1828
Mesaconitine was incubated with rat liver microsomes in vitro. The metabolites of mesaconitine in rat liver microsomes were identified by ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method with high resolution power. A typical reaction mixture of 100 mol L-1 Tris-HCI buffer (pH 7.4) containing 0.5 gL-1 microsomal protein and 50 micro molL-1 mesaconitine was prepared. The above reaction mixture was divided into six groups, and the volume of each group was 200 micro L. The incubation mixture was pre-incubated at 37 degrees C for 2 min and the reactions were initiated by adding NADPH generating system. After 90 min incubation at 37 degrees C, 200 micro L of acetonitrile was added to each group to stop the reaction. The metabolites of mesaconitine were investigated by UPLC-MS/MS method. Mesaconitine and 6 metabolites M1-M6 were found in the incubation system. The structures were characterized according to the data from MS/MS spectra and literatures. The metabolic reactions of mesaconitine in rat liver microsomes included the demethylation, deacetylation, dehydrogenation and hydroxylation. The major metabolic pathways of mesaconitine in rat liver microsomes were determined by UPLC-MS/MS on multiple reaction monitoring (MRM) mode combined with specific inhibitors of cytochrome P450 (CYP) isoforms, including alpha-naphthoflavone (CYP1A2), quinine (CYP2D), diethyldithiocarbamate (CYP2E1), ketoconazole (CYP3A) and sulfaphenazole (CYP2C), separately. Mesaconitine was mainly metabolized by CYP3A. CYP2C and CYP2D were also more important CYP isoforms for the metabolism reactions of mesaconitine, but CYP1A2 and CYP2E1 haven't any contribution to MA metabolism in rat liver microsomes.
Aconitine
;
analogs & derivatives
;
metabolism
;
Animals
;
Chromatography, High Pressure Liquid
;
Cytochrome P-450 CYP3A
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
Cytochrome P-450 Enzyme Inhibitors
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Enzyme Inhibitors
;
pharmacology
;
Ketoconazole
;
pharmacology
;
Male
;
Metabolic Networks and Pathways
;
Microsomes, Liver
;
enzymology
;
metabolism
;
Quinine
;
pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Sulfaphenazole
;
pharmacology
;
Tandem Mass Spectrometry
4.In vitro metabolism of glycyrrhetic acid by human cytochrome P450.
Li LIU ; Juan XIAO ; Zhi-Hong PENG ; Yong CHEN
Acta Pharmaceutica Sinica 2011;46(1):81-87
Licorice root has been frequently used as antitode in traditional Chinese medicine. As the main active component of Licorice root, glycyrrhetic acid (GA) is mainly metabolized in liver. This study was designed to investigate the in vitro metabolism of GA by human liver microsomes (HLM) and human recombinant cytochrome P450 (CYP) isoforms. The results indicated that GA was metabolized mainly by CYP3A4. The K(m), V(max) and CL(int) of GA in HLM were 18.6 micromol x L(-1), 4.4 nmol x mg(-1) (protein) x min(-1) and 0.237 mL x mg(-1) (protein) x min(-1), respectively. At concentration up to 50 micromol x L(-1), GA inhibited CYP2C19, CYP2C9 and CYP3A4 enzyme activities with the inhibitory potencies up to 50%.
Aryl Hydrocarbon Hydroxylases
;
antagonists & inhibitors
;
metabolism
;
Cytochrome P-450 CYP2C19
;
Cytochrome P-450 CYP2C9
;
Cytochrome P-450 CYP3A
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
Enzyme Inhibitors
;
pharmacology
;
Glycyrrhetinic Acid
;
isolation & purification
;
pharmacokinetics
;
pharmacology
;
Glycyrrhiza
;
chemistry
;
Humans
;
Isoenzymes
;
metabolism
;
Microsomes, Liver
;
enzymology
;
metabolism
;
Plant Roots
;
chemistry
;
Plants, Medicinal
;
chemistry
5.Effects of Ayurvedic Rasayana botanicals on CYP3A4 isoenzyme system.
Swapnil P BORSE ; Bhagyashree B KAMBLE
Journal of Integrative Medicine 2015;13(3):165-172
<p>OBJECTIVEConsuming botanical dietary supplements or herbal drugs along with prescription drugs may lead to potential pharmacokinetic-pharmacodynamic (PK-PD) herb-drug interactions (HDI). The present study focuses on the importance of and novel approach for assessing HDI in integrative medicine with case examples of two frequently-used Ayurvedic Rasayana botanicals.p><p>METHODSThe aqueous extracts of Asparagus racemosus (ARE) and Gymnema sylvester (GSE) were prepared as per Ayurvedic Pharmacopoeia of India. Chemoprofiling of these extracts was done using high-performance liquid chromatography (HPLC). Additionally, ARE was characterized for the presence of shatavarins IV and I using HPLC & mass spectroscopy respectively. Effects of ARE and GSE were investigated on rat liver microsome using testosterone probe drug assay. The changes in formation of metabolite (6-β hydroxy testosterone) were monitored on incubation of testosterone alone, testosterone with ketoconazole, ARE and GSE using HPLC. Half inhibitory concentration (IC50) was used to predict plausible HDI.p><p>RESULTSARE and GSE showed no inhibition with IC50 values >1 000 μg/mL while the standard inhibitor ketoconazole completely abolished CYP3A4-dependent activity at 0.531 μg/mL and IC50 was found to be 0.036 μg/mL.p><p>CONCLUSIONARE and GSE prepared as per Ayurvedic Pharmacopoeia of India were found to be safe for CYP3A4-mediated inhibitory HDI in rats. Our in vitro study suggests the need of further in vivo investigation for HDI in order to provide clinical relevance.p>
Animals
;
Asparagus Plant
;
Chromatography, High Pressure Liquid
;
Cytochrome P-450 CYP3A
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
pharmacology
;
Gymnema sylvestre
;
Herb-Drug Interactions
;
Isoenzymes
;
antagonists & inhibitors
;
Plant Extracts
;
pharmacology
;
Rats
;
Rats, Wistar
6.Inhibitory effect of PNS on drug metabolism enzyme CYP3A in rat livers and its kinetic analysis.
China Journal of Chinese Materia Medica 2012;37(22):3486-3489
<p>OBJECTIVETo study the inhibitory effect of total saponins of the root and rhizome of Panax notoginseng (PNS) on drug metabolism enzyme CYP3A in rat livers and its kinetic analysis.p><p>METHODMicrosome enzyme was prepared by differential velocity centrifugation. Michaelis constant (Km) and maximum velocity (Vmax) of CYP3A, 50% inhibitory concentration of PNS on CYP3A, and the inhibition type and the inhibition constant of CYP3A (Ki, Kis) of PNS on CYP3A were calculated by Lineweaver-Burk and the low of semi-effect-probit.p><p>RESULTTotal saponins of the root and rhizome of panax notoginseng inhibited CYP3A activity, with IC50 of 689.54 mg x L(-1). Compared with the substrate aminopyrine, CYP3A showed Km of 0.036 mmol x L(-1) and Vmax of 21.01 micromol min(-1) x g(-1). Total saponins of the root and rhizome of panax notoginseng showed a mixed inhibition on CYP3A, with the inhibition constants of 247.79 mg x L(-1) (Ki) and 321.79 mg x L(-1) (Kis).p><p>CONCLUSIONTotal saponins of the root and rhizome of panax notoginseng have a significant effect on CYP3A activity in rat livers.p>
Animals
;
Cytochrome P-450 CYP3A
;
chemistry
;
genetics
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
Enzyme Inhibitors
;
chemistry
;
pharmacology
;
Kinetics
;
Liver
;
chemistry
;
drug effects
;
enzymology
;
Male
;
Panax notoginseng
;
chemistry
;
Rats
;
Rats, Sprague-Dawley
;
Rhizome
;
chemistry
;
Saponins
;
chemistry
;
pharmacology
7.Quantitative prediction of in vivo drug-drug interactions based on in vitro inhibition or/and induction data for CYP3A4.
Acta Pharmaceutica Sinica 2010;45(8):952-959
Inhibition or/and induction of CYP3A4 are the major mechanisms underlying the common clinical drug-drug interactions, which has been gained attention in new drug discovery and development as well as clinical practice. Quantitative prediction of drug-drug interactions at the early stage of drug development is advantageous for reducing the cost and duration of development and providing more information for the later clinical studies. The review summarizes the update progress on quantitative prediction of in vivo drug-drug interactions derived from models based on in vitro inhibition or/and induction for CYP3A4.
Area Under Curve
;
Cytochrome P-450 CYP3A
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
Drug Interactions
;
Enzyme Inhibitors
;
pharmacology
;
Humans
;
Intestines
;
metabolism
;
Liver
;
metabolism
;
Models, Biological
;
Pharmaceutical Preparations
;
administration & dosage
;
metabolism
8.In vitro inhibition of five traditional Chinese medicine injections on rat liver microsomal CYP3A.
Yonglong HAN ; Xiangle MENG ; Dan LI ; Zhiyong ZHOU ; Qi YU ; Yan LI ; Cheng GUO
China Journal of Chinese Materia Medica 2011;36(4):492-495
<p>OBJECTIVEQingkailing injection (QKLI), Jinnaduo injection (JNDI), Shuxuetong injection (SXTI), Shenmai injection (SMI) and Kangai injection (KAI) are widely used in China. To predict the herb-drug interactions in clinical application, they were evaluated for their in vitro inhibition effect on CYP3A in rat liver microsomes.p><p>METHODThe rat liver microsomes were incubated with different doses of 5 kinds of traditional Chinese medicine injections (TCMIs) in the present of testosterone, a specific substrate of CYP3A. 6beta-hydroxytestosterone, the metabolite of testosterone, was monitored by HPLC to compare the inhibition effect of 5 TCMIs on CYP3A in rat liver microsomes. Ketoconazole was used as a positive control.p><p>RESULT10% QKLI reduced the formation of 6beta-hydroxytestosterone by approximately 93.0%, which is more significant than other four TCMIs. The half maximal inhibitory concentration (IC50) and the enzyme-inhibitor constant K(i) were 1.0% and 0.7% respectively.p><p>CONCLUSIONQKLI showed much stronger inhibition activity against CYP3A, comparing to other 4 TCMIs. The results revealed that QKLI may be involved in herb-drug interactions by inhibition of CYP3A.p>
Animals
;
Cytochrome P-450 CYP3A Inhibitors
;
Injections
;
Male
;
Medicine, Chinese Traditional
;
Microsomes, Liver
;
drug effects
;
enzymology
;
Rats
;
Rats, Sprague-Dawley
9.Investigation of metabolic kinetics and reaction phenotyping of ligustrazin by using liver microsomes and recombinant human enzymes.
Yan TAN ; Xiao-Mei ZHUANG ; Guo-Lin SHEN ; Hua LI ; Yue GAO
Acta Pharmaceutica Sinica 2014;49(3):374-379
The metabolic characteristics of ligustrazin (TMPz) in liver microsomes were investigated in the present study. The reaction phenotyping of TMPz metabolism was also identified by in vitro assessment using recombinant human cytochrome P450 enzymes (CYP) and UDP glucuronosyltransferases (UGT). TMPz was incubated at 37 degrees C with human (HLM) and rat liver microsomes (RLM) in the presence of different co-factors. The metabolic stability and enzyme kinetics of TMPz were studied by determining its remaining concentrations with a LC-MS/MS method. TMPz was only metabolically eliminated in the microsomes with NADPH or NADPH+UDPGA. In the HLM and RLM with NADPH+UDPGA, t1/2, K(m) and V(max) of TMPz were 94.24 +/- 4.53 and 105.07 +/- 9.44 min, 22.74 +/- 1.89 and 33.09 +/- 2.74 micromol x L(-1), 253.50 +/- 10.06 and 190.40 +/- 8.35 nmol x min(-1) x mg(-1) (protein), respectively. TMPz showed a slightly higher metabolic rate in HLM than that in RLM. Its primary oxidative metabolites, 2-hydroxymethyl-3, 5, 6-trimethylpyrazine (HTMP), could undergo glucuronide conjugation. The CYP reaction phenotyping of TMPz metabolism was identified using a panel of recombinant CYP isoforms (rCYP) and specific CYP inhibitors in HLM. CYP1A2, 2C9 and 3A4 were found to be the major CYP isoforms involved in TMPz metabolism. Their individual contributions were assessed b) using the method of the total normalized rate to be 19.32%, 27.79% and 52.90%, respectively. It was observed that these CYP isoforms mediated the formation of HTMP in rCYP incubation. The UGT reaction phenotyping of HTMP glucuronidation was also investigated preliminarily by using a panel of 6 UGT isoforms (rUGT). UGT1A1, 1A4 and 1A6 were the predominant isoforms mediated the HTMP glucuronidation. The results above indicate that the metabolism of TMPz involves multiple enzymes mediated phase I and phase II reactions.
Animals
;
Cytochrome P-450 CYP1A2
;
metabolism
;
Cytochrome P-450 CYP2C9
;
metabolism
;
Cytochrome P-450 CYP3A
;
metabolism
;
Cytochrome P-450 Enzyme Inhibitors
;
Cytochrome P-450 Enzyme System
;
metabolism
;
Drug Interactions
;
Glucuronosyltransferase
;
metabolism
;
Humans
;
Ligusticum
;
chemistry
;
Microsomes, Liver
;
enzymology
;
NADP
;
metabolism
;
pharmacology
;
Pyrazines
;
metabolism
;
pharmacokinetics
;
Rats
;
Uridine Diphosphate Glucuronic Acid
;
metabolism
;
pharmacology
10.Study on metabolism of tetramethylpyrazine in system of rat liver microsomes.
Xiao-dong KUANG ; Xi-hua LI ; Yu-qing XIONG
China Journal of Chinese Materia Medica 2006;31(23):1971-1975
<p>OBJECTIVEThe metabolic character of tetramethylpyrazine (TMPz) in rat liver microsomes was studied in vitro and in vivo to identify which isoforms of cytochrome P450 were responsible for TMPz metabolism in rats, offer the theoretical foundation for the fact that it is rational to use medicine in clinic.p><p>METHODSet up UV- HPLC method of TMPz, determine concentration of TMPz and its formation in rat plasma and liver microsomes incubation solution, analyze the correlation between TMPz's metabolic eliminate rate and each inducer. Erythromycin( ERY) N-demethylase activity of each sample in rat liver microsomes was measured using N-demethylation reaction of ERY as probe. The correlation between the rate of TMPz metabolite formation and the demethylase activity was analysed. After the SD rats who had been treated with inducer, inhibitor, or untreated, received administration of TMPz in vein, the plasma concentration of TMPz were determined by HPLC. Pharmacokinetic parameters of TMPz were computed and compared.p><p>RESULTThe disppearing rate of TMPz in the incubation solutions of the rats liver microsomes, which treated with DEX, were markedly quicker than that of control group (P < 0. 01) , while no obvious difference between P-NF group or PB and control group was observed (P > 0. 05). The activity of ERY-N-demethylase in DEX-induced group was corespondingly enhanced, was much higer than that in control group. The correlation between the rate of TMPz metabolic product formation and the activity of N-demethylase was significant. After using Ket, the CYP3A inhibitor, the metabolism of TMPz could be significantly inhibited the metabolism of TMPz in rat liver microsomes. In vivo, CL( s) were larger than that of the control group,t,/2 were smaller than the control group in DEX group; By contrary, CL(s) was smaller than the control group,t1/2 was larger than the control group in Ket group.p><p>CONCLUSIONResults suggest that CYP3A plays a major role in TMPz metabolism in rats, TMPz lie in the possibility of Interaction among the medicines between TMPz and CYP3A inducers or inhibitors when they are used in clinic.p>
Animals
;
Cytochrome P-450 CYP3A
;
metabolism
;
Cytochrome P-450 CYP3A Inhibitors
;
Dexamethasone
;
pharmacology
;
Ketoconazole
;
pharmacology
;
Male
;
Metabolic Clearance Rate
;
Microsomes, Liver
;
drug effects
;
enzymology
;
metabolism
;
Pyrazines
;
blood
;
metabolism
;
pharmacokinetics
;
Random Allocation
;
Rats
;
Rats, Wistar
;
Vasodilator Agents
;
blood
;
metabolism
;
pharmacokinetics